Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Finished Goods (2020 - 2022)

Historic Finished Goods for Rapid Micro Biosystems (RPID) over the last 3 years, with Q2 2022 value amounting to $8.0 million.

  • Rapid Micro Biosystems' Finished Goods rose 16547.38% to $8.0 million in Q2 2022 from the same period last year, while for Jun 2022 it was $8.0 million, marking a year-over-year increase of 16547.38%. This contributed to the annual value of $4.3 million for FY2021, which is 32125.37% up from last year.
  • Per Rapid Micro Biosystems' latest filing, its Finished Goods stood at $8.0 million for Q2 2022, which was up 16547.38% from $5.9 million recorded in Q1 2022.
  • In the past 5 years, Rapid Micro Biosystems' Finished Goods registered a high of $8.0 million during Q2 2022, and its lowest value of $1.0 million during Q4 2020.
  • Its 3-year average for Finished Goods is $4.2 million, with a median of $3.7 million in 2021.
  • In the last 5 years, Rapid Micro Biosystems' Finished Goods soared by 32125.37% in 2021 and then soared by 16547.38% in 2022.
  • Rapid Micro Biosystems' Finished Goods (Quarter) stood at $1.0 million in 2020, then surged by 321.25% to $4.3 million in 2021, then skyrocketed by 86.28% to $8.0 million in 2022.
  • Its last three reported values are $8.0 million in Q2 2022, $5.9 million for Q1 2022, and $4.3 million during Q4 2021.